載入...

Somatostatin receptor radionuclide therapy in neuroendocrine tumors

Peptide receptor radionuclide therapy (PRRT) using (177)Lu-DOTATATE has been approved for the treatment of gastroenteropancreatic NETs. An understanding of benefits and risks is important for the appropriate implementation of this therapy. This review summarizes study data supporting the use of radi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Endocr Relat Cancer
Main Authors: Haider, Mintallah, Das, Satya, Al-Toubah, Taymeyah, Pelle, Eleonora, El-Haddad, Ghassan, Strosberg, Jonathan
格式: Artigo
語言:Inglês
出版: 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8118168/
https://ncbi.nlm.nih.gov/pubmed/33608483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0360
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!